Protalix BioTherapeutics Inc (PLX)
1.76
+0.02
(+1.15%)
USD |
NYAM |
Dec 20, 16:00
1.755
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Profit Margin (Quarterly): 18.02% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Accuray Inc | -3.89% |
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.54% |
| Return on Assets | -11.58% |
| Return on Invested Capital | -19.69% |
| Gross Profit Margin (Quarterly) | 53.37% |
| Operating Margin (Quarterly) | 22.22% |
| Return on Net Operating Assets | -26.05% |